Financhill
Back

DermTech 10K Form

Sell
20

DMTK
DermTech

Last Price:
0.59
Seasonality Move:
-9.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DMTK News And Ratings

See the #1 stock for the next 7 days that we like better than DMTK

DMTK Financial Statistics

Sales & Book Value

Annual Sales: $15.3M
Cash Flow: $-12.54M
Price / Cash Flow: 0
Annual Sales: $1.66
Price / Book: 0.36

Profitability

EPS (TTM): -3.14000
Net Income (TTM): $-100.89M
Gross Margin: $276K
Return on Equity: -110.16%
Return on Assets: -63.36%

DermTech Earnings Forecast

Key DermTech Financial Ratios

  • The Gross Profit Margin over the past 5 years for DMTK is 1.80%.
  • The Selling, General & Administrative Expenses for DMTK have been equal to 580.39% of Gross Profit Margin.
  • The Research & Development expenses have been 99.63% of Revenue.
  • The Interest Expense is -13.20% of Operating Income.
  • The Net Earning history of DMTK is -659.57% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

DermTech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DMTK
CUSIP: 24984K
Website: dermtech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.59
Quick Ratio: 4.35

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DMTK Technical Analysis vs Fundamental Analysis

Sell
20
DermTech (DMTK) is a Sell

Is DermTech a Buy or a Sell?

  • DermTech stock is rated a Sell
    The current DermTech [DMTK] share price is $0.60. The Score for DMTK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.